Vitrue Health

Vitrue Health are developing medical devices that refocus healthcare onto quality of life.

We bring “precision medicine” to musculoskeletal (MSK) healthcare based on augmented functional assessments and predictive machine learning algorithms.

MSK affects 9.6 million adults in the U.K., a full quarter of the adult population. Evidence shows that many people are not receiving the right care. For example the most common treatment for osteoarthritis is joint replacement or arthroplasty. In the UK there were 243,000 joint replacement procedures performed in 2016/17, a 10% increase on the previous year. Around half of these are Total Hip Arthroplasties but for 30% of recipients’ arthroplasty was an inappropriate form of treatment. This is a waste of £243million per year as well as representing a huge detriment to patient’s quality of life.

By improving the accuracy, efficiency and predictive power of functional assessment Vitrue will empower physiotherapists, occupational therapists and doctors to implement interventions that will not only vastly improve patient outcomes and generate huge savings for the NHS but also reduce key headline issues such as delayed transfers of care and emergency readmissions.

Venturefest Oxford

The 2019 event will be on  Wednesday 11th September at Oxford Brookes University. 

Find out more >



Innovation Showcase

The showcase welcomed the most innovative and exciting business innovations. 

Find out more >

Pitching for Success

Venturefest's elevator pitch competition. Sponsored by Penningtons Manches.

Find out more >

Get Connected

Get connected with key business support services from across Oxfordshire.

Find out more >

Our Partners